MK-4815, a Potential New Oral Agent for Treatment of Malaria

Antimicrobial Agents and Chemotherapy, 04/25/2012

MK–4815 is inexpensive to synthesize, an important characteristic for providing affordable antimalaria therapy to the developing world. The attractive biological and pharmaceutical profile of MK–4815 demonstrates its potential for use in combination with other agents in the fight against malaria.

Print Article Summary Cat 2 CME Report